Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 45963-142

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 45963-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Bupropion Hydrochloride. (Image 1)

FDA Label Image

300mg (Image 2)

300mg (Image 2)
This is a medication guide for a drug called "P-i-el" once daily 300 in extended-release tablets form. The medication contains hydrochloride and must be stored in a tight, light-resistant container. The dosage should be taken daily, and users should not exceed the recommended dosage. The text also provides a warning not to use this medication in combination with another drug called "ZYBAN®" or any other medicines that contain bupropion hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.